Several studies have suggested that hyperhomocysteinemia contributes to the development of diabetic nephropathy (DN) and retinopathy (DR) in patients with diabetes, especially those with MTHFR polymorphisms [109,110]. This evidence concerns the gene MTHFR and hyperhomocysteinemia.